SCHEMBL5373201

SCHEMBL5373201

NC(=O)c1cccc(C(N)=O)c1CC(F)(F)F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.42
ALDH1A1 P00352 3/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
TSHR P16473 1/20 0.42
HSD17B10 Q99714 1/20 0.42
PARP1 P09874 7/20 0.41
PDK2 Q15119 1/20 0.41
METAP2 P50579 1/20 0.39
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
XBP1 P17861 1/20 0.39
KMT2A Q03164 1/20 0.39
GAA P10253 1/20 0.39
BCAT2 O15382 1/20 0.38
KEAP1 Q14145 1/20 0.38
NFE2L2 Q16236 1/20 0.38
PDPK1 O15530 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
RPS6KB1 P23443 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1116681 0.89 MAPK8 (0.44) KDM4EALDH1A1MAPTHPGDTSHR
SCHEMBL1116586 0.88 KMT2A (0.50) KDM4EALDH1A1MAPTHPGDTSHR
SCHEMBL363265 0.78 KDM4E (0.45) KDM4EALDH1A1MAPTHPGDTSHR
Hydrochloric Acid SCHEMBL28047477 0.77 KDM4E (0.44) KDM4EALDH1A1MAPTHPGDTSHR
Hydrochloric Acid SCHEMBL27491870 0.77 KDM4E (0.44) KDM4EALDH1A1MAPTHPGDTSHR
SCHEMBL2096743 0.77 P2RX7 (0.41) KDM4EALDH1A1MAPTHPGDTSHR
SCHEMBL8580446 0.76 KDM4E (0.50) KDM4EALDH1A1MAPTHPGDTSHR
SCHEMBL10923208 0.74 BCAT2 (0.48) KDM4EALDH1A1MAPTHPGDTSHR
SCHEMBL32661225 0.73 PARP1 (0.47) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL29286662 0.73 CD38 (0.46) PARP1LMNAGAARPS6KB1AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7176242-B2 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives ELAN PHARMACEUTICALS, INC. (US) 2007-02-13 US claimed
EP-1453789-A2 N,N'-SUBSTITUTED-1,3-DIAMINO-2-HYDROXYPROPANE DERIVATIVES Elan Pharmaceuticals, Inc. (US) 2004-09-08 EP claimed
US-20040171881-A1 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives PHARMACIA & UPJOHN COMPANY 2004-09-02 US claimed
WO-2003040096-A2 N, N'-SUBSTITUTED-1,3-DIAMINO-2-HYDROXYPROPANE DERIVATIVES ELAN PHARMACEUTICALS, INC. (US) 2003-05-15 WO claimed
EP-4317162-B1 1,3-BENZODIOXOLANE-CONTAINING COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF XIAN XINTONG PHARMACEUTICAL RES CO LTD (CN) 2026-02-04 EP disclosed
US-20240059694-A1 COMPOUND CONTAINING 1,3-BENZODIOXOL STRUCTURE AND PREPARATION METHOD AND USE THEREOF XI'AN XINTONG PHARMACEUTICAL RESEARCH CO., LTD. (CN) 2024-02-22 US disclosed
EP-4317162-A1 1,3-BENZODIOXOLANE-CONTAINING COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF Xi'An Xintong Pharmaceutical Research Co., Ltd. (CN) 2024-02-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040171881-A1 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives BACE1, BACE2, PSEN1 KDM4E 4309/4885ALDH1A1 527/4885MAPT 675/4885
US-20240059694-A1 COMPOUND CONTAINING 1,3-BENZODIOXOL STRUCTURE AND PREPARATION METHOD AND USE THEREOF BTK, JAK3, JAK1 KDM4E 852/4885ALDH1A1 1855/4885MAPT 4789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.